Elmar A Joura

Elmar A Joura

UNVERIFIED PROFILE

Are you Elmar A Joura?   Register this Author

Register author
Elmar A Joura

Elmar A Joura

Publications by authors named "Elmar A Joura"

Are you Elmar A Joura?   Register this Author

52Publications

1984Reads

20Profile Views

The impact of p16 positivity in invasive vulvar cancer on disease-free and disease-specific survival, a retrospective study.

Arch Gynecol Obstet 2020 Mar 22;301(3):753-759. Epub 2020 Jan 22.

Department of Gynecology and Obstetrics, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00404-020-05431-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060959PMC
March 2020

Human papillomavirus vaccination: The ESGO-EFC position paper of the European society of Gynaecologic Oncology and the European Federation for colposcopy.

Eur J Cancer 2019 Jul 1;116:21-26. Epub 2019 Jun 1.

Division of Gynaecological Oncology, Department of Obstetrics and Gynaecology, Hacettepe University Faculty of Medicine, Ankara, Turkey.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09598049193028
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2019.04.032DOI Listing
July 2019

SPERANZA project: HPV vaccination after treatment for CIN2.

Gynecol Oncol 2018 11 6;151(2):229-234. Epub 2018 Sep 6.

Medical University of Vienna, AKH Department of Obstetrics and Gynecology, Comprehensive Cancer Center Vienna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2018.08.033DOI Listing
November 2018

Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15-26 Years of Age.

Obstet Gynecol 2018 08;132(2):261-270

Department of Microbiology Infectious Diseases, the Royal Women's Hospital, Department of Microbiology, the Royal Children's Hospital, Infection and Immunity, Murdoch Children's Research Institute, Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Australia; the Department of Gynecology and Obstetrics, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; the Department of Obstetrics and Gynecology, University of Kansas Medical Center, Kansas City, Kansas; Institut Catala d'Oncologia, IDIBELL, CIBER-ESP, RTICC, L'Hospitalet de Llobregat, Barcelona, Spain; the Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana; the Department of Pathology, SMBD Jewish General Hospital and McGill University, Montréal, Québec, Canada; the Department of Obstetrics and Gynecology, Augusta University, Augusta, Georgia; the Center for Infection Research in Cancer, Moffitt Cancer Center, Tampa, Florida; the National Institute of Public Health, Cuernavaca, Morelos, Mexico; the Division of Gynecologic Oncology, University of Alabama, Birmingham, Alabama; the Department of Clinical Science, University of Bergen/Haukeland University Hospital, Bergen, Norway; the Danish Cancer Society Research Center, Copenhagen, Denmark and Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Johns Hopkins University School of Medicine, Baltimore, Maryland; the Department of Obstetrics and Gynecology, Clinica Colsanitas, Fundacion Universitaria Sanitas, Bogota, Colombia; Institut du col, Paris, France; the National Institute of Cancer, Bogotá, Colombia; the Department of Obstetrics and Gynecology, University Central Hospital, Helsinki, Finland; the Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Direction des Risques Biologiques et de la Santé au Travail, Institut National de Santé Publique du Québec, Montréal, Québec, Canada; Robert E. Fechner Laboratory of Surgical Pathology, University of Virginia Health System, Charlottesville, Virginia; the Departments of Pathology and Obstetrics and Gynecology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico; UCLA School of Nursing, Los Angeles, California; Merck & Co, Inc., Kenilworth, New Jersey; Universidad del Rosario, Bogota, Colombia; and Analytica LASÉR, Montréal, Québec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/AOG.0000000000002736DOI Listing
August 2018

HPV prevalence in vulvar cancer in Austria.

Wien Klin Wochenschr 2017 Nov 7;129(21-22):805-809. Epub 2017 Sep 7.

Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00508-017-1255-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676822PMC
November 2017

An open-label, randomized study of a 9-valent human papillomavirus vaccine given concomitantly with diphtheria, tetanus, pertussis and poliomyelitis vaccines to healthy adolescents 11-15 years of age.

Pediatr Infect Dis J 2015 Jun;34(6):627-34

From the *Department of Pediatrics, Khon Kaen University, Khon Kaen, Thailand; †Coordinating Research Centre, Frederiksberg Hospital, Denmark; ‡Vaccine Research Center, University of Tampere, Tampere, Finland; §Paulinenstr. 71 a, Detmold, Germany; ¶Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium; ‖Department of Gynecology and Obstetrics, Medical University of Vienna, Vienna, Austria; and Departments of **Clinical Research Vaccines and ††Biostatistics, Merck & Co., Inc., Kenilworth, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/INF.0000000000000694DOI Listing
June 2015

A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.

N Engl J Med 2015 Feb;372(8):711-23

From the Medical University of Vienna, Comprehensive Cancer Center, Vienna (E.A.J.); Moffitt Cancer Center, Tampa, FL (A.R.G.); Department of Clinical Medicine, University of Bergen-Haukeland University Hospital, Bergen, Norway (O.-E.I.); Université Laval, Québec, QC (C.B.), and University of British Columbia, Vancouver (G.S.) - both in Canada; University of Washington, Seattle (C.M.); Coordinating Research Center, Frederiksberg Hospital, University of Copenhagen (J.M.), and Danish Cancer Society Research Center and Department of Gynecology, Rigshospitalet (S.K.K.) - all in Copenhagen; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Brazilian Ministry of Health, Bahia, Brazil (E.D.M.); University of Hong Kong, Hong Kong (Y.N.); Aarhus University Hospital, Department of Obstetrics and Gynecology, Aarhus, Denmark (L.K.P.); Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico (E.L.-P.); Faculty of Tropical Medicine, Mahidol University, Nakhon Pathom, Thailand (P.P.); Investigación Clínica, Medellín, Colombia (J.A.R.); Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (L.W.); Mackay Memorial Hospital, Taipei, Taiwan (Y.C.Y.); Wolfson Institute of Preventive Medicine, London (J. Cuzick); Royal Women's Hospital, University of Melbourne and Murdoch Childrens Research Institute, Parkville, VIC, Australia (S.M.G.); Division of Gynecologic Oncology, University of Alabama, Birmingham (W.H.); and Merck, Whitehouse Station, NJ (O.M.B., I.S.F.C., J. Chen, R.G., E.M., M.R., S.V., A.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1405044DOI Listing
February 2015

What do women with gynecologic cancer know about HPV and their individual disease? A pilot study.

BMC Cancer 2014 May 30;14:388. Epub 2014 May 30.

Department of Obstetrics and Gynecology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://bmccancer.biomedcentral.com/articles/10.1186/1471-240
Publisher Site
http://dx.doi.org/10.1186/1471-2407-14-388DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046847PMC
May 2014

Human papillomavirus in high-grade cervical lesions: Austrian data of a European multicentre study.

Wien Klin Wochenschr 2013 Oct 17;125(19-20):591-9. Epub 2013 Sep 17.

Department of Gynaecology and Obstetrics, Comprehensive Cancer Center, Medical University of Vienna, Währingergürtel 18-20, 1090, Vienna, Austria,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00508-013-0403-6DOI Listing
October 2013

Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data.

BMJ 2012 Mar 27;344:e1401. Epub 2012 Mar 27.

Department of Gynaecology and Obstetrics, Medical University of Vienna, Comprehensive Cancer Center, Währinger Gürtel 18-20, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314184PMC
http://dx.doi.org/10.1136/bmj.e1401DOI Listing
March 2012

Prevalence of human papillomavirus types 6, 11, 16 and 18 in young Austrian women - baseline data of a phase III vaccine trial.

Wien Klin Wochenschr 2008 ;120(21-22):666-71

Department of Gynecology and Obstetrics, Women's Health Clinic, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s00508-008-1093
Web Search
http://link.springer.com/10.1007/s00508-008-1093-3
Publisher Site
http://dx.doi.org/10.1007/s00508-008-1093-3DOI Listing
February 2010

Cervical cancer and vaccination--an overview.

Authors:
Elmar A Joura

Eur J Cancer 2009 Sep;45 Suppl 1:457-8

Department of Obstetrics and Gynaecology, Division of Gynaecologic Oncology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0959-8049(09)70088-7DOI Listing
September 2009

Cervical cancers after human papillomavirus vaccination.

Obstet Gynecol 2009 Jul;114(1):174-5

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/AOG.0b013e3181aa8f9fDOI Listing
July 2009

Human papillomavirus infections and vulvar disease development.

Cancer Epidemiol Biomarkers Prev 2009 Jun;18(6):1777-84

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Medical University of Vienna, Allgemeines Krankenhaus der Stadt Wien, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-09-0067DOI Listing
June 2009

Human papilloma virus infection prior to coitarche.

Am J Obstet Gynecol 2009 May 9;200(5):487.e1-5. Epub 2009 Mar 9.

Department of Gynecology and Obstetrics, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2008.12.028DOI Listing
May 2009

[Cervix carcinoma--Austrian Vaccination Committee recommends HPV vaccination].

Wien Med Wochenschr 2007 ;157(5-6):130-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10354-007-0395-9DOI Listing
August 2007

Groin metastasis after extensive microinvasive vulvar cancer. A case report.

J Reprod Med 2007 Feb;52(2):78-80

Department of Gynecology and Pathology, Medical University of Vienna, Allgemeines Krankenhaus, Vienna, Austria.

View Article

Download full-text PDF

Source
February 2007

[Human papillomavirus and cervical cancer: presence and future of vaccination].

Authors:
Elmar A Joura

Gynakol Geburtshilfliche Rundsch 2004 Jun;44(3):142-5

Abteilung für Gynäkologie und gynäkologische Onkologie, Universitätsklinik für Frauenheilkunde, Wien, Osterreich.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000077860DOI Listing
June 2004

Thrombocytosis and anaemia in women with recurrent ovarian cancer prior to a second-line chemotherapy.

Anticancer Res 2003 May-Jun;23(3C):2991-4

Department of Gynecology and Obstetrics, Vienna University Medical School, A-1090 Vienna, Währinger Gürtel 18-20, Austria.

View Article

Download full-text PDF

Source
September 2003

The impact of a single- or double-layer closure on uterine rupture.

Am J Obstet Gynecol 2003 Sep;189(3):895; author reply 895-6

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1067/s0002-9378(03)00637-9DOI Listing
September 2003

Basic fibroblast growth factor and hypertensive disorders in pregnancy.

Hypertens Pregnancy 2002 ;21(3):235-41

Department of Obstetrics and Gynecology, University of Vienna, 1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1081/PRG-120016790
Publisher Site
http://dx.doi.org/10.1081/PRG-120016790DOI Listing
March 2003

Elevated serum concentrations of androgens in women with pregnancy-induced hypertension.

Wien Klin Wochenschr 2003 Mar;115(5-6):162-6

Department of Obstetrics and Gynecology, University Hospital of Vienna, General Hospital Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/bf03040303DOI Listing
March 2003

Serum levels of squamous cell carcinoma antigen as a predictor of inguinofemoral lymph node metastasis in patients with vulvar cancer.

J Reprod Med 2002 Sep;47(9):718-20

Department of Gynecology and Obstetrics, University of Vienna General Hospital, Währinger Gürtel 18-20, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
September 2002

Epidemiology, diagnosis and treatment of vulvar intraepithelial neoplasia.

Authors:
Elmar A Joura

Curr Opin Obstet Gynecol 2002 Feb;14(1):39-43

Department of Gynecology and Obstetrics, University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00001703-200202000-00007DOI Listing
February 2002

A randomized trial of vaginal prostaglandin E2 for induction of labor. Insert vs. tablet.

J Reprod Med 2002 Feb;47(2):115-9

Department of Obstetrics and Gynecology, University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.

View Article

Download full-text PDF

Source
February 2002